Assessing adherence and persistence to non-vitamin k antagonist oral anticoagulants (NOACs) among patients with atrial fibrillation in tertiary-care referral centers in Malaysia

QR Code

Assessing adherence and persistence to non-vitamin k antagonist oral anticoagulants (NOACs) among patients with atrial fibrillation in tertiary-care referral centers in Malaysia

Introduction: Non-vitamin K antagonist oral anticoagulants (NOACs), such as dabigatran and rivaroxaban, are now available for stroke prevention in patients with atrial fibrillation (AF) and are often clinically preferred over vitamin K antagonists (VKAs), such as warfarin. Data describing adherence...

Full description

Bibliographic Details
Main Authors:	Kubas, Mohammed A., Shabaruddin, Fatiha Hana, Mazlan-Kepli, Wardati, Jagan, Nirmala, Mohamed, Sahimi, Mohamed Nazar, Nor Ilyani, Zin, Che Suraya
Format:	Article
Language:	English English
Published:	Wolters Kluwer Medknow Publications 2020
Subjects:	RM Therapeutics. Pharmacology
Online Access:	http://irep.iium.edu.my/81695/ http://irep.iium.edu.my/81695/12/81695_Assessing%20adherence%20and%20persistence%20to%20non-vitamin_baru.pdf http://irep.iium.edu.my/81695/18/zin_kubas.pdf

Similar Items

Assessing adherence to direct oral anticoagulants (DOACs) among patients with atrial fibrillation in tertiary-care referral centers in Malaysia
by: Kubas, Mohammed Abdullah, et al.
Published: (2019)

Systematic review of adherence to direct oral anticoagulants in patients with atrial fibrilation in clinical practice
by: Kubas, Mohammed Abdullah, et al.
Published: (2018)

Adherence to Oral Anticoagulants in Atrial Fibrillation: An Australian Survey
by: Obamiro, K., et al.
Published: (2018)

A Summary of the Literature Evaluating Adherence and Persistence with Oral Anticoagulants in Atrial Fibrillation
by: Obamiro, K., et al.
Published: (2016)

Anticoagulation knowledge in patients with atrial fibrillation: An Australian survey
by: Obamiro, K., et al.
Published: (2018)

Changes in Oral Anticoagulant Prescribing for Stroke Prevention in Patients With Atrial Fibrillation
by: Admassie, E., et al.
Published: (2017)

Anticoagulant use in patients with nonvalvular atrial fibrillation: has prescribing improved?
by: Bista, D., et al.
Published: (2016)

The relationship between knowledge, health literacy, and adherence among patients taking oral anticoagulants for stroke thromboprophylaxis in atrial fibrillation
by: Rolls, C., et al.
Published: (2017)

The Tasmanian atrial fibrillation study: Transition to direct oral anticoagulants 2011-2015
by: Alamneh, E., et al.
Published: (2017)

Suboptimal use of oral anticoagulants in atrial fibrillation: Has the introduction of direct oral anticoagulants improved prescribing practices?
by: Alamneh, E., et al.
Published: (2016)

Use of anticoagulants and antiplatelet agents in stable outpatients with coronary artery disease and atrial fibrillation. International clarify registry
by: Fauchier, L., et al.
Published: (2015)

Knowledge of atrial fibrillation and stroke prevention: development of questionnaire and validation of results
by: Mohamed, Sahimi, et al.
Published: (2017)

Knowledge of Atrial Fibrillation and Stroke Prevention: Development of Questionnaire and Validation of Results
by: Sahimi, Mohamed, et al.
Published: (2016)

Non-adherence to Thromboprophylaxis Guidelines in Atrial Fibrillation: A Narrative Review of the Extent of and Factors in Guideline Non-adherence
by: Gebreyohannes, Eyob Alemayehu, et al.
Published: (2020)

Impact of gout on the risk of atrial fibrillation
by: Kuo, Chang-Fu, et al.
Published: (2016)

Screening for atrial fibrillation in primary care
by: Taggar, Jaspal
Published: (2017)

Bleeding-related admissions in patients with atrial fibrillation receiving antithrombotic therapy: results from the Tasmanian Atrial Fibrillation
by: Admassie, E., et al.
Published: (2017)

Association between use of non–vitamin k oral anticoagulants with and without concurrent medications and risk of major bleeding in nonvalvular atrial fibrillation
by: Chang, Shang-Hung, et al.
Published: (2017)

Thromboembolism and Mortality in the Tasmanian Atrial Fibrillation Study
by: Admassie, E., et al.
Published: (2018)

ENVIRONMENTAL SUSTAINABILITY APPRAISAL OF THE ATRIAL FIBRILLATION CARE PATHWAY
by: Munawar, Sana
Published: (2016)

Assessment Of Medication Adherence, Knowledge, And Health-Related Quality Of Life Among Atrial Fibrillation Patients Using Warfarin In Penang, Malaysia
by: Matalqah, Laila Mahmoud Ali
Published: (2014)

Protocol to assess the effectiveness and safety of novel oral anticoagulants (NOAC) vs warfarin in real world settings: cohort study in primary care
by: Hippisley-Cox, Julia, et al.
Published: (2016)

Screening for atrial fibrillation in primary care: from recommendation to implementation
by: Taggar, Jaspal, et al.
Published: (2016)

Stroke prevention in atrial fibrillation: An update on current management strategies
by: Hall, Toby, et al.
Published: (2013)

A rare case of vein of galen thrombosis: exploring a potential role for novel oral anticoagulants (NOACs) in cerebral deep vein thrombosis
by: Inche Mat, Liyana Najwa, et al.
Published: (2017)

Patient Characteristics and Antithrombotic Prescribing Patterns in Patients with Atrial Fibrillation in Tasmania
by: Bista, D., et al.
Published: (2017)

Safety and efficacy of dabigatran versus warfarin in Asian patients with atrial fibrillation
by: Inche Mat, Liyana Najwa, et al.
Published: (2020)

The Clinical Outcome Evaluation On The Atrial Fibrillation Patients Receiving Warfarin For Secondary Stroke Prevention In The Medication Therapy Adherence Clinic In Serdang And Seremban Hospitals
by: Mochamad Djunaedi, Mochamad Djunaedi
Published: (2016)

The burden and implications of preoperative atrial fibrillation in Australian heart valve surgery patients
by: Russell, E., et al.
Published: (2017)

Early experiences with edoxaban for stroke prevention in atrial fibrillation in the Southeast Asia region
by: Bimbo Diaz, Alejandro, et al.
Published: (2023)

Potential use of NOACs in developing countries: Pros and cons
by: Bista, D., et al.
Published: (2014)

Successful intravenous thrombolysis of a wake-up stroke with underlying valvular atrial fibrillation
by: Koya Kutty, Shahedah, et al.
Published: (2018)

Screening for atrial fibrillation – a cross-sectional survey of healthcare professionals in primary care
by: Taggar, Jaspal, et al.
Published: (2016)

Postoperative atrial fibrillation after isolated aortic valve replacement: A cause for concern?
by: Saxena, A., et al.
Published: (2013)

Type 2 diabetes, glucose homeostasis and incident atrial fibrillation: The Atherosclerosis risk in communities study
by: Huxley, Rachel, et al.
Published: (2012)

Atrial fibrillation and cognitive decline-the role of subclinical cerebral infarcts: The atherosclerosis risk in communities study
by: Chen, L., et al.
Published: (2014)

Blood lipids and the incidence of atrial fibrillation: The multi-ethnic study of atherosclerosis and the framingham heart study
by: Alonso, A., et al.
Published: (2014)

Physical activity, obesity, weight change, and risk of atrial fibrillation the atherosclerosis risk in communities study
by: Huxley, Rachel, et al.
Published: (2014)

Impact of periprocedural atrial fibrillation on short-term clinical outcomes following percutaneous coronary intervention
by: Chan, W., et al.
Published: (2012)

Percentage of time in therapeutic range and proportion of thromboembolic event in nonvalvular atrial fibrillation patient on warfarin
by: Mohd, Fahmi Nazrin
Published: (2015)